Omrix's IPO

Omrix raised a round of funding on April 20, 2006. Investors include Public.

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…

Articles about Omrix's IPO: